Your session is about to expire
← Back to Search
JK07 for Heart Failure
Study Summary
This trial is testing a new drug to treat heart failure. The drug will be given to a small group of people to see if it is safe and effective. The group will be given either the new drug or a placebo, and the study will see if the new drug works better than the placebo.
- Heart Failure with Reduced Ejection Fraction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the Food and Drug Administration officially accepted JK07 for clinical use?
"JK07 has yet to be clinically evaluated in depth, so it recieved a score of 1."
How many participants are being recruited for this trial?
"Salubris Biotherapeutics Inc has determined that 63 individuals fulfilling the requirements for this trial are required to complete its successful execution. The research will be conducted across two sites, Hospital of the University of Pennsylvania in Philadelphia and Stanford University Medical Center in California."
Who would be most suitable to take part in this medical experiment?
"Aspiring participants must have been diagnosed with heart failure and be between 18-80 years old to join this medical trial. Currently, 63 patients are being sought out for enrollment in the study."
Are there any facilities administering this research in the North American region?
"At this time, 9 medical centres have been authorised to recruit participants for the trial. This includes facilities in Philadelphia, Stanford and Boston among other cities. To minimise travel expenses associated with participation, selecting a centre closest to you is advisable."
Does this experiment accept participants older than seventy years of age?
"The enrollment requirements for this clinical trial stipulate that participants must be at least 18 years of age, but not exceed 80."
Are there still open slots available for participants in this trial?
"As noted on clinicaltrials.gov, this trial is searching for volunteers to take part in the study. It was initiated on September 21st 2020 and last updated November 3rd 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger